Capital International Investors Novo Nordisk A S Transaction History

Capital International Investors

  • $488 Billion
  • Q1 2025

A detailed history of Capital International Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital International Investors holds 9,511,545 shares of NVO stock, worth $663 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
9,511,545
Previous 6,754,420 40.82%
Holding current value
$663 Million
Previous $581 Million 13.68%
% of portfolio
0.14%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$69.3 - $90.95 $191 Million - $251 Million
2,757,125 Added 40.82%
9,511,545 $660 Million
Q4 2024

Feb 13, 2025
SELL
$85.0 - $120.04 $17.4 Million - $24.6 Million
-204,594 Reduced 2.94%
6,754,420 $581 Million
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $247,665 - $302,473
-2,080 Reduced 0.03%
6,959,014 $829 Million
Q2 2024

Aug 13, 2024
SELL
$122.71 - $146.91 $15.2 Million - $18.3 Million
-124,239 Reduced 1.75%
6,961,094 $994 Million
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $3.02 Million - $4.02 Million
-29,598 Reduced 0.42%
7,085,333 $910 Million
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $114 Million - $137 Million
1,297,536 Added 22.3%
7,114,931 $736 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $213 Million - $467 Million
2,342,009 Added 67.39%
5,817,395 $529 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $31.9 Million - $35.3 Million
-204,313 Reduced 5.55%
3,475,386 $562 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $336 Million - $404 Million
-2,540,876 Reduced 40.85%
3,679,699 $586 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $6.08 Million - $8.02 Million
-59,284 Reduced 0.94%
6,220,575 $842 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $5.53 Million - $6.79 Million
58,068 Added 0.93%
6,279,859 $628 Million
Q2 2022

Aug 15, 2022
BUY
$103.24 - $121.81 $92.5 Million - $109 Million
896,241 Added 16.83%
6,221,791 $689 Million
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $30.5 Million - $36.9 Million
-327,493 Reduced 5.79%
5,325,550 $596 Million
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $17.2 Million - $21 Million
179,049 Added 3.27%
5,653,043 $631 Million
Q3 2021

Nov 15, 2021
BUY
$84.42 - $106.62 $11.1 Million - $14 Million
131,106 Added 2.45%
5,473,994 $526 Million
Q2 2021

Aug 16, 2021
BUY
$67.66 - $84.76 $18.3 Million - $22.9 Million
270,517 Added 5.33%
5,342,888 $448 Million
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $23.7 Million - $26.8 Million
353,783 Added 7.5%
5,072,371 $343 Million
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $8.74 Million - $10.1 Million
136,767 Added 2.98%
4,718,588 $330 Million
Q3 2020

Nov 13, 2020
SELL
$63.69 - $70.22 $12.5 Million - $13.8 Million
-195,993 Reduced 4.1%
4,581,821 $320 Million
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $152 Million - $177 Million
2,601,458 Added 119.53%
4,777,814 $313 Million
Q1 2020

May 15, 2020
BUY
$49.46 - $64.78 $13.9 Million - $18.2 Million
281,520 Added 14.86%
2,176,356 $131 Million
Q4 2019

Feb 18, 2020
BUY
$49.86 - $58.26 $27.8 Million - $32.5 Million
558,446 Added 41.79%
1,894,836 $110 Million
Q3 2019

Nov 14, 2019
BUY
$47.54 - $53.43 $24.8 Million - $27.8 Million
520,897 Added 63.88%
1,336,390 $69.1 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $27,138 - $30,432
580 Added 0.07%
815,493 $41.6 Million
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $83 - $94
-2 Reduced -0.0%
814,913 $37.5 Million
Q3 2018

Nov 14, 2018
BUY
$46.76 - $51.24 $17 Million - $18.6 Million
363,500 Added 80.52%
814,915 $38.4 Million
Q1 2018

May 15, 2018
BUY
$48.49 - $58.14 $48 - $58
1 Added 0.0%
451,415 $22.2 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $18.6 Million - $22.2 Million
451,414
451,414 $21.7 Million

Others Institutions Holding NVO

# of Institutions
1,761
Shares Held
340M
Call Options Held
11.3M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $157B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email